Starpharma Holdings Limited (SPHRY)


Other OTC - Other OTC Delayed Price. Currency in USD
5.120.00 (0.00%)
At close: 11:53 AM EDT
People also watch:
SPHRFSPL.AXPSDVFEICTINY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close5.12
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market Cap189M
P/E Ratio (ttm)-9.49
Beta0.48
Volume0
Avg Vol (3m)2,860
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube7 days ago

    ETF’s with exposure to Starpharma Holdings Ltd. : September 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Starpharma Holdings Ltd. Here are 5 ETF’s with the largest exposure to SPHRY-US. Comparing the performance and risk of Starpharma Holdings Ltd. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Starpharma Holdings Ltd. :SPHRY-US: Earnings Analysis: For the six months ended June 30, 2016 : September 13, 2016
    Capital Cube17 days ago

    Starpharma Holdings Ltd. :SPHRY-US: Earnings Analysis: For the six months ended June 30, 2016 : September 13, 2016

    Categories: Yahoo Finance Get free summary analysis Starpharma Holdings Ltd. reports financial results for the half-year ended June 30, 2016. We analyze the earnings along side the following peers of Starpharma Holdings Ltd. – Dow Chemical Company, Chimerix, Inc., Astrazeneca PLC Sponsored ADR, Alere Inc. and Johnson & Johnson (DOW-US, CMRX-US, AZN-US, ALR-US and JNJ-US) that have also ... Read more (Read more...)

  • Business Wire17 days ago

    Starpharma: VivaGel® Condom Receives Regulatory Approval in Canada

    Starpharma Holdings Ltd today announced it had been granted a medical device license for the VivaGel® condom by the Canadian regulatory authority, Health Canada.